Autism-Open Access
Open Access

Abstract

The Fever Effect: Do Kids With Autism Do Better When They Use a Device To Warm Their Blood? Effects of a 6-week AVACEN Treatment Method on Autism Spectrum Disorder

Thomas Muehlbauer*

Objective: To evaluate the effects of the AVACEN Treatment Method (ATM) device on parent-reported language and sleep outcomes in children with Autism Spectrum Disorder (ASD). 

Methods: Thirteen children (ages 4.5 to 17.1 years) diagnosed with ASD were enrolled in a six-week, randomized, double-blind, placebo-controlled trial. Participants were randomly assigned to one of three experimental groups: (1) Heat with negative pressure (n=4), (2) Heat only (n=4), or (3) Placebo (no heat or pressure) (n=5). Caregivers conducted two 20-minute sessions per day at home using the AVACEN (Advanced VAscular Circulation ENhancement) device. Observations on language use and sleep quality were collected at baseline, midpoint, and study conclusion through daily logbooks. 

Results: Children in the active treatment group demonstrated the most consistent improvements across all measured sleep and language domains. In this group, 4 out of 4 participants were reported to have experienced longer, deeper sleep and greater expressive language use, including increased vocabulary and social engagement. Reported language and sleep improvements in the control groups were modest but varied. 

Discussion: These preliminary findings suggest that the AVACEN device may offer a safe, non-invasive approach to improving core behavioral challenges in ASD, particularly in sleep and communication. Larger controlled trials using objective outcome measures are warranted to confirm efficacy and support potential clearance by the United States Food & Drug Administration (FDA) for use in pediatric populations with neurodevelopmental disorders.

Published Date: 2026-01-19; Received Date: 2025-12-18